ATC classification. Cardiovascular system
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01A CARDIAC GLYCOSIDES
C01B ANTIARRHYTHMICS, CLASS I AND III
C01BA Antiarrhythmics, class Ia
C01BA02 — procainamide (, ATC/DDD)
C01BA03 — disopyramide (, ATC/DDD)
C01BB Antiarrhythmics, class Ib
C01BB01 — lidocaine (, ATC/DDD)
C01BB02 — mexiletine (, ATC/DDD)
C01BC Antiarrhythmics, class Ic
C01BC03 — propafenone (, ATC/DDD)
C01BC04 — flecainide (, ATC/DDD)
C01BD Antiarrhythmics, class III
C01BD01 — amiodarone (, ATC/DDD)
C01BD05 — ibutilide (, ATC/DDD)
C01BD07 — dronedarone (, ATC/DDD)
C01BG Other antiarrhythmics, class I and III
C01BG11 — vernakalant (, ATC/DDD)
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA02 — isoprenaline (, ATC/DDD)
C01CA03 — norepinephrine (, ATC/DDD)
C01CA04 — dopamine (, ATC/DDD)
C01CA06 — phenylephrine (, ATC/DDD)
C01CA07 — dobutamine (, ATC/DDD)
C01CA17 — midodrine (, ATC/DDD)
C01CA24 — epinephrine (, ATC/DDD)
C01CA26 — ephedrine (, ATC/DDD)
C01CE Phosphodiesterase inhibitors
C01CE02 — milrinone (, ATC/DDD)
C01D VASODILATORS USED IN CARDIAC DISEASES
C01DA02 — glyceryl trinitrate (, ATC/DDD)
C01DA08 — isosorbide dinitrate (, ATC/DDD)
C01DA14 — isosorbide mononitrate (, ATC/DDD)
C01DX Other vasodilators used in cardiac diseases
C01DX22 — vericiguat (, ATC/DDD)
C01E OTHER CARDIAC PREPARATIONS
C01EA01 — alprostadil (, ATC/DDD)
C01EB Other cardiac preparations
C01EB10 — adenosine (, ATC/DDD)
C01EB17 — ivabradine (, ATC/DDD)
C01EB18 — ranolazine (, ATC/DDD)
C01EB24 — mavacamten (, ATC/DDD)
C02 ANTIHYPERTENSIVES
C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
C02AB02 — methyldopa (racemic) (, ATC/DDD)
C02AC Imidazoline receptor agonists
C02AC01 — clonidine (, ATC/DDD)
C02AC02 — guanfacine (, ATC/DDD)
C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02CA Alpha-adrenoreceptor antagonists
C02CA01 — prazosin (, ATC/DDD)
C02CA04 — doxazosin (, ATC/DDD)
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DB Hydrazinophthalazine derivatives
C02DB02 — hydralazine (, ATC/DDD)
C02DC01 — minoxidil (, ATC/DDD)
C02DD Nitroferricyanide derivatives
C02DD01 — nitroprusside (, ATC/DDD)
C02K OTHER ANTIHYPERTENSIVES
C02KX — antihypertensives for pulmonary arterial hypertension (, ATC/DDD)
C02KX01 — bosentan (, ATC/DDD)
C02KX02 — ambrisentan (, ATC/DDD)
C02KX04 — macitentan (, ATC/DDD)
C02KX05 — riociguat (, ATC/DDD)
C02KX54 — macitentan and tadalafil (, ATC/DDD)
C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02
C03 DIURETICS
C03A LOW-CEILING DIURETICS, THIAZIDES
C03AA03 — hydrochlorothiazide (, ATC/DDD)
C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES
C03BA04 — chlortalidone (, ATC/DDD)
C03BA08 — metolazone (, ATC/DDD)
C03BA11 — indapamide (, ATC/DDD)
C03BD — xanthine derivatives (, ATC/DDD)
C03C HIGH-CEILING DIURETICS
C03CA01 — furosemide (, ATC/DDD)
C03CA02 — bumetanide (, ATC/DDD)
C03CC Aryloxyacetic acid derivatives
C03CC01 — etacrynic acid (, ATC/DDD)
C03D POTASSIUM-SPARING AGENTS
C03DA01 — spironolactone (, ATC/DDD)
C03DA04 — eplerenone (, ATC/DDD)
C03DA05 — finerenone (, ATC/DDD)
C03DB Other potassium-sparing agents
C03DB01 — amiloride (, ATC/DDD)
C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION
C03EA Low-ceiling diuretics and potassium-sparing agents
C03EA01 — hydrochlorothiazide and potassium-sparing agents (, ATC/DDD)
C03X OTHER DIURETICS
C03XA01 — tolvaptan (, ATC/DDD)
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS
C04AB01 — phentolamine (, ATC/DDD)
C04AD03 — pentoxifylline (, ATC/DDD)
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AA01 — hydrocortisone (, ATC/DDD)
C05AD07 — pramocaine (, ATC/DDD)
C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
C05AX03 — other preparations, combinations (, ATC/DDD)
C05B ANTIVARICOSE THERAPY
C05BA Heparins or heparinoids for topical use
C05BA04 — pentostan polysulfate sodium (, ATC/DDD)
C05BB Sclerosing agents for local injection
C05BB04 — sodium tetradecyl sulphate (, ATC/DDD)
C05BB56 — glucose, combinations (, ATC/DDD)
C05C CAPILLARY STABILIZING AGENTS
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA03 — pindolol (, ATC/DDD)
C07AA05 — propranolol (, ATC/DDD)
C07AB Beta blocking agents, selective
C07AB02 — metoprolol (, ATC/DDD)
C07AB03 — atenolol (, ATC/DDD)
C07AB04 — acebutolol (, ATC/DDD)
C07AB07 — bisoprolol (, ATC/DDD)
C07AB12 — nebivolol (, ATC/DDD)
C07AB14 — landiolol (, ATC/DDD)
C07AG Alpha and beta blocking agents
C07AG01 — labetalol (, ATC/DDD)
C07AG02 — carvedilol (, ATC/DDD)
C07B BETA BLOCKING AGENTS AND THIAZIDES
C07C BETA BLOCKING AGENTS AND OTHER DIURETICS
C07CA Beta blocking agents, non-selective, and other diuretics
C07CA03 — pindolol and other diuretics (, ATC/DDD)
C07CB Beta blocking agents, selective, and other diuretics
C07CB03 — atenolol and other diuretics (, ATC/DDD)
C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS
C07E BETA BLOCKING AGENTS AND VASODILATORS
C07F BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES
C08 CALCIUM CHANNEL BLOCKERS
C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08CA Dihydropyridine derivatives
C08CA01 — amlodipine (, ATC/DDD)
C08CA02 — felodipine (, ATC/DDD)
C08CA05 — nifedipine (, ATC/DDD)
C08CA06 — nimodipine (, ATC/DDD)
C08CA16 — clevidipine (, ATC/DDD)
C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
C08DA Phenylalkylamine derivatives
C08DA01 — verapamil (, ATC/DDD)
C08DB Benzothiazepine derivatives
C08DB01 — diltiazem (, ATC/DDD)
C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09A ACE INHIBITORS, PLAIN
C09AA01 — captopril (, ATC/DDD)
C09AA02 — enalapril (, ATC/DDD)
C09AA03 — lisinopril (, ATC/DDD)
C09AA04 — perindopril (, ATC/DDD)
C09AA05 — ramipril (, ATC/DDD)
C09AA06 — quinapril (, ATC/DDD)
C09AA07 — benazepril (, ATC/DDD)
C09AA08 — cilazapril (, ATC/DDD)
C09AA09 — fosinopril (, ATC/DDD)
C09AA10 — trandolapril (, ATC/DDD)
C09B ACE INHIBITORS, COMBINATIONS
C09BA ACE inhibitors and diuretics
C09BA02 — enalapril and diuretics (, ATC/DDD)
C09BA03 — lisinopril and diuretics (, ATC/DDD)
C09BA04 — perindopril and diuretics (, ATC/DDD)
C09BA05 — ramipril and diuretics (, ATC/DDD)
C09BA06 — quinapril and diuretics (, ATC/DDD)
C09BA08 — cilazapril and diuretics (, ATC/DDD)
C09BB ACE inhibitors and calcium channel blockers
C09BB04 — perindopril and amlodipine (, ATC/DDD)
C09C ANGIOTENSIN II ANTAGONISTS, PLAIN
C09CA Angiotensin II antagonists, plain
C09CA01 — losartan (, ATC/DDD)
C09CA03 — valsartan (, ATC/DDD)
C09CA04 — irbesartan (, ATC/DDD)
C09CA06 — candesartan (, ATC/DDD)
C09CA07 — telmisartan (, ATC/DDD)
C09CA08 — olmesartan medoxomil (, ATC/DDD)
C09CA09 — azilsartan medoxomil (, ATC/DDD)
C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DA Angiotensin II antagonists and diuretics
C09DA01 — losartan and diuretics (, ATC/DDD)
C09DA03 — valsartan and diuretics (, ATC/DDD)
C09DA04 — irbesartan and diuretics (, ATC/DDD)
C09DA06 — candersartan and diuretics (, ATC/DDD)
C09DA07 — telmisartan and diuretics (, ATC/DDD)
C09DA08 — olmesartan medoxomil and diuretics (, ATC/DDD)
C09DA09 — azilsartant medoximil and diuretics (, ATC/DDD)
C09DB Angiotensin II antagonists and calcium channel blockers
C09DB04 — telmisartan and amlodipine (, ATC/DDD)
C09DX Angiotensin II antagonists, other combinations
C09DX04 — valsartan and sacubitril (, ATC/DDD)
C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AA HMG CoA reductase inhibitors
C10AA01 — simvastatin (, ATC/DDD)
C10AA02 — lovastatin (, ATC/DDD)
C10AA03 — pravastatin (, ATC/DDD)
C10AA04 — fluvastatin (, ATC/DDD)
C10AA05 — atorvastatin (, ATC/DDD)
C10AA07 — rosuvastatin (, ATC/DDD)
C10AB02 — bezafibrate (, ATC/DDD)
C10AB04 — gemfibrozil (, ATC/DDD)
C10AB05 — fenofibrate (, ATC/DDD)
C10AC01 — colestyramine (, ATC/DDD)
C10AC02 — colestipol (, ATC/DDD)
C10AC04 — colesevelam (, ATC/DDD)
C10AX Other lipid modifying agents
C10AX — other lipid modifying agents (, ATC/DDD)
C10AX09 — ezetimibe (, ATC/DDD)
C10AX12 — lomitapide (, ATC/DDD)
C10AX13 — evolocumab (, ATC/DDD)
C10AX14 — alirocumab (, ATC/DDD)
C10AX16 — inclisiran (, ATC/DDD)
C10AX17 — evinacumab (, ATC/DDD)
